M. Showkat Ali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
M. Showkat Ali has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Paul Farmer
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia
2 shared publicationsKarl Fernstrom
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
1 shared publicationPeter P. Sayeski
Department of Physiology and Functional Genomics, University of Florida College of Medicine, P.O. Box 100274, Gainesville, FL 32610, USA
1 shared publicationThanh Doan
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
1 shared publicationThomas Cooney
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
1 shared publication
Latest Publications
- 14 July 2005
- Published by Wiley in Journal of Cellular Physiology
- Vol. 205 (3) , 402-413
Cytoskeletal remodeling in vascular smooth muscle cells in response to angiotensin II‐induced activation of the SHP‐2 tyrosine phosphatase
Angiotensin II is an octapeptide that regulates diverse cellular responses including the actin cytoskeletal organization. In this study, stable cell lines overexpressing wild‐type or catalytically inactive SHP‐2 were employed to elucidate the signaling pathway utilized by the SHP‐2 tyrosine phosphatase that mediates an angiotensin II‐induced reorganization of the actin cytoskeleton in vascular smooth muscle cells (VSMC). The expression of wild‐type SHP‐2 prevented an angiotensin II dependent increase in stress fiber formation. In contrast, the catalytically inactive mutant SHP‐2 increased stress fiber formation. Additional observations further established that SHP‐2 regulates the reorganization of the actin cytoskeleton through RhoA‐ and Vav2‐dependent signaling pathways. The expression of wild‐type SHP‐2 caused a dephosphorylation of several focal adhesion associated proteins including paxillin, p130Cas, and tensin in VSMC. This dephosphorylation of focal adhesion associated proteins was accompanied by significantly decreased numbers of focal adhesions within cells. These results demonstrate a unique role for SHP‐2 in the regulation of the cellular architecture of VSMC, suggesting the possibility that this phosphatase might be instrumental in vascular remodeling.
- 14 July 2005
- Published by Wiley in Journal of Cellular Physiology
- Vol. 205 (3) , 402-413
Cytoskeletal remodeling in vascular smooth muscle cells in response to angiotensin II‐induced activation of the SHP‐2 tyrosine phosphatase
Angiotensin II is an octapeptide that regulates diverse cellular responses including the actin cytoskeletal organization. In this study, stable cell lines overexpressing wild‐type or catalytically inactive SHP‐2 were employed to elucidate the signaling pathway utilized by the SHP‐2 tyrosine phosphatase that mediates an angiotensin II‐induced reorganization of the actin cytoskeleton in vascular smooth muscle cells (VSMC). The expression of wild‐type SHP‐2 prevented an angiotensin II dependent increase in stress fiber formation. In contrast, the catalytically inactive mutant SHP‐2 increased stress fiber formation. Additional observations further established that SHP‐2 regulates the reorganization of the actin cytoskeleton through RhoA‐ and Vav2‐dependent signaling pathways. The expression of wild‐type SHP‐2 caused a dephosphorylation of several focal adhesion associated proteins including paxillin, p130Cas, and tensin in VSMC. This dephosphorylation of focal adhesion associated proteins was accompanied by significantly decreased numbers of focal adhesions within cells. These results demonstrate a unique role for SHP‐2 in the regulation of the cellular architecture of VSMC, suggesting the possibility that this phosphatase might be instrumental in vascular remodeling.
- 1 March 2004
- Published by Elsevier in Cellular Signalling
- Vol. 16 (3) , 301-311
Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells
- 1 March 2004
- Published by Elsevier in Cellular Signalling
- Vol. 16 (3) , 301-311
Selective down-regulation of angiotensin II receptor type 1A signaling by protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells
- 15 July 2003
- Published by Elsevier in Experimental Cell Research
- Vol. 287 (2) , 339-349
The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation
- 15 July 2003
- Published by Elsevier in Experimental Cell Research
- Vol. 287 (2) , 339-349
The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation